CCSI

Consensus is a deeply cash-generative but slow-melting niche software business, and the market is pricing it as a terminal decliner. Revenue has drifted flat-to-down for four years ($362M FY22 → $350M FY25, -0.2% YoY), and net income has eroded from $109M in FY21 to $84.5M in FY25 (-5.5% YoY). The MD&A shows why: the legacy SoHo (small-office cloud fax) book is structurally shrinking — SoHo revenue fell from $141.3M to $127.0M (-10%) as accounts dropped from 721k to 638k. The offset is Corporate, which grew from $209.1M to $222.7M (+6.5%) and now drives ~64% of revenue via stickier API-connected, regulated-industry customers (healthcare, public sector). This mix shift is the whole investment case: if Corporate can carry the top line to flat/growing, the current valuation is far too pessimistic.

And the valuation is the reason to own it. At $37.94 the stock trades at 8.7x FY25 diluted EPS of $4.35 and just 2.0x sales, against a business printing 79.8% gross, 43.0% operating and 24.2% net margins. Cash conversion is excellent — operating cash flow of $136M (+11.8%) against $30.2M of capex leaves roughly $106M of free cash flow, so the equity yields ~15% on FCF at a $716M market cap. Management is returning that cash: buybacks jumped to $23.2M and share count fell 3.4% to 18.9M, which is highly accretive at single-digit multiples. Cash more than doubled to $74.7M and current debt fell 62.7%, signaling balance-sheet repair.